Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Roberto Guariglia, Maria Carmen Martorelli, Rosa Lerose, Donatella Telesca, Maria Rita Milella & Pellegrino Musto. (2016) Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients. Biologics: Targets and Therapy 10, pages 1-8.
Read now
Read now
Jonathan Hoggatt, Tiffany A Tate & Louis M Pelus. (2015) Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia. International Journal of Nanomedicine 10, pages 2647-2652.
Read now
Read now
Articles from other publishers (19)
Zhixuan You, Haotian Zhang, Yining Huang, Lei Zhao, Hengjia Tu, Yuzhuo Zhang, Xinqing Lin & Wenhua Liang. (2023) Assessing the Optimal Regimen: A Systematic Review and Network Meta-Analysis of the Efficacy and Safety of Long-Acting Granulocyte Colony-Stimulating Factors in Patients with Breast Cancer. Cancers 15:14, pages 3675.
Crossref
Crossref
Abdulrahman Theyab, Khalaf F. Alsharif, Khalid J. Alzahrani, Atif Abdulwahab A. Oyouni, Yousef MohammedRabaa Hawsawi, Mohammad Algahtani, Saad Alghamdi & Amal F. Alshammary. (2023) New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy. Frontiers in Oncology 12.
Crossref
Crossref
Xiaofeng Huang, Shuo Li, Wenjie Shi, Ye Wang, Xinyu Wan, Jinzhi He, Yinggang Xu, Weiwei Zhang, Xiaoqing Shi, Rui Chen, Lu Xu, Xiaoming Zha & Jue Wang. (2022) A prospective, randomized clinical trial of emergency treatment of chemotherapy‐induced neutropenia and febrile neutropenia by pegylated recombinant human granulocyte colony‐stimulating factor (PEG‐rhG‐CSF). British Journal of Clinical Pharmacology 89:1, pages 372-379.
Crossref
Crossref
Susan Miller, Walter Moos, Barbara Munk, Stephen Munk, Charles Hart & David Spellmeyer. 2023. Managing the Drug Discovery Process. Managing the Drug Discovery Process
339
415
.
Shuhang Wang, Keman Cheng, Kun Chen, Chen Xu, Peiwen Ma, Guohui Dang, Yuqi Yang, Qi Lei, Huiyao Huang, Yue Yu, Yuan Fang, Qiyu Tang, Ning Jiang, Huilei Miao, Funan Liu, Xiao Zhao & Ning Li. (2022) Nanoparticle-based medicines in clinical cancer therapy. Nano Today 45, pages 101512.
Crossref
Crossref
Rebecca S. Hofford, Tanner J. Euston, Rashaun S. Wilson, Katherine R. Meckel, Emily G. Peck, Arthur Godino, Joseph A. Landry, Erin S. Calipari, TuKiet T. Lam & Drew D. Kiraly. (2021) Granulocyte-Colony Stimulating Factor Reduces Cocaine-Seeking and Downregulates Glutamatergic Synaptic Proteins in Medial Prefrontal Cortex. The Journal of Neuroscience 41:7, pages 1553-1565.
Crossref
Crossref
Ritu Karwasra, Surender Singh, Khalid Raza, Nitin Sharma & Saurabh Varma. (2021) A brief overview on current status of nanomedicines for treatment of pancytopenia: Focusing on chemotherapeutic regime. Journal of Drug Delivery Science and Technology 61, pages 102159.
Crossref
Crossref
Agata Szade, Krzysztof Szade, Witold N Nowak, Karolina Bukowska‐Strakova, Lucie Muchova, Monika Gońka, Monika Żukowska, Maciej Cieśla, Neli Kachamakova‐Trojanowska, Marzena Rams‐Baron, Alicja Ratuszna, Józef Dulak & Alicja Józkowicz. (2019)
Cobalt protoporphyrin
IX
increases endogenous G‐
CSF
and mobilizes
HSC
and granulocytes to the blood
. EMBO Molecular Medicine 11:12.
Crossref
Crossref
Anton Popov, Arunas Stirke, Neringa Bakute, Benediktas Brasiunas, Arunas Ramanavicius & Almira Ramanaviciene. (2019) Efficiency of granulocyte colony-stimulating factor immobilized on magnetic microparticles on proliferation of NFS-60 cells. Colloids and Surfaces A: Physicochemical and Engineering Aspects 578, pages 123580.
Crossref
Crossref
Nadia Harbeck, Jessie Wang, Gordon Philipp Otto, Sreekanth Gattu & Andriy Krendyukov. (2019) Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies. Future Oncology 15:12, pages 1313-1322.
Crossref
Crossref
Liem Andhyk Halim, Maripaz Márquez, Roel F. Maas-Bakker, Gilberto Castañeda-Hernández, Wim Jiskoot & Huub Schellekens. (2018) Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product. Pharmaceutical Research 35:11.
Crossref
Crossref
Kimberly Blackwell, Roman Donskih, C. Michael Jones, Allen Nixon, Maria J. Vidal, Roumen Nakov, Pritibha Singh, Gregor Schaffar, Pere Gascón & Nadia Harbeck. (2016) A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial. The Oncologist 21:7, pages 789-794.
Crossref
Crossref
R Navarro-Martínez, E Chover-Sierra & O Cauli. (2015) Non-chemotherapy drug-induced agranulocytosis in a tertiary hospital. Human & Experimental Toxicology 35:3, pages 244-250.
Crossref
Crossref
Lisa Bregoli, Dania Movia, James D. Gavigan-Imedio, Joanne Lysaght, John Reynolds & Adriele Prina-Mello. (2016) Nanomedicine applied to translational oncology: A future perspective on cancer treatment. Nanomedicine: Nanotechnology, Biology and Medicine 12:1, pages 81-103.
Crossref
Crossref
Sarfaraz Niazi. 2015. Biosimilars and Interchangeable Biologics. Biosimilars and Interchangeable Biologics
1
22
.
Anastasia S Proskurina, Tatiana S Gvozdeva, Ekaterina A Alyamkina, Evgenia V Dolgova, Konstantin E Orishchenko, Valeriy P Nikolin, Nelly A Popova, Sergey V Sidorov, Elena R Chernykh, Alexandr A Ostanin, Olga Y Leplina, Victoria V Dvornichenko, Dmitriy M Ponomarenko, Galina S Soldatova, Nikolay A Varaksin, Tatiana G Ryabicheva, Stanislav N Zagrebelniy, Vladimir A Rogachev, Sergey S Bogachev & Mikhail A Shurdov. (2015) Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage II-IV breast cancer. BMC Cancer 15:1.
Crossref
Crossref
Xianxing Xu, Jingwen Yang, Yunlong Liu, Chengqi Shan, Qiushi Wang, Zhihang Chen & Yuanguo Cheng. (2015) The Induction of Prolonged Myelopoietic Effects in Monkeys by GW003, A Recombinant Human Granulocyte Colony-Stimulating Factor Genetically Fused to Recombinant Human Albumin. Journal of Pharmaceutical Sciences 104:2, pages 760-767.
Crossref
Crossref
Bo Qu, Guo-Rong Xin, Li-Xia Zhao, Hui Xing, Li-Ying Lian, Hai-Yan Jiang, Jia-Zhao Tong, Bei-Bei Wang & Shi-Zhu Jin. (2014) Testing Stem Cell Therapy in a Rat Model of Inflammatory Bowel Disease: Role of Bone Marrow Stem Cells and Stem Cell Factor in Mucosal Regeneration. PLoS ONE 9:10, pages e107891.
Crossref
Crossref
Michal Hofer, Milan Pospíšil, Denisa Komůrková & Zuzana Hoferová. (2014) Granulocyte Colony-Stimulating Factor in the Treatment of Acute Radiation Syndrome: A Concise Review. Molecules 19:4, pages 4770-4778.
Crossref
Crossref